|
CCDC90B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.67390000042012E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79430000249548E-08 |
| Normal-vs-Stage2 |
4.656800E-03 |
| Normal-vs-Stage3 |
2.381800E-02 |
| Normal-vs-Stage4 |
1.074170E-02 |
| Stage1-vs-Stage2 |
9.393600E-01 |
| Stage1-vs-Stage3 |
4.895200E-03 |
| Stage1-vs-Stage4 |
5.324300E-02 |
| Stage2-vs-Stage3 |
1.204400E-01 |
| Stage2-vs-Stage4 |
2.306000E-01 |
| Stage3-vs-Stage4 |
6.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31930000041503E-07 |
| Normal-vs-AfricanAmerican |
6.370500E-02 |
| Normal-vs-Asian |
3.246400E-01 |
| Caucasian-vs-AfricanAmerican |
4.097800E-02 |
| Caucasian-vs-Asian |
5.292000E-01 |
| AfricanAmerican-vs-Asian |
9.835000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53297999999635E-05 |
| Normal-vs-Female |
3.24819999997228E-06 |
| Male-vs-Female |
5.660600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.576500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.41260000000132E-06 |
| Normal-vs-Age(61-80Yrs) |
2.28469999999925E-05 |
| Normal-vs-Age(81-100Yrs) |
1.866950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.373200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.438800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.224400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.372400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.707800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.891000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.754000E-04 |
| Normal-vs-Grade 2 |
5.22109999678833E-08 |
| Normal-vs-Grade 3 |
5.020500E-04 |
| Normal-vs-Grade 4 |
6.730400E-02 |
| Grade 1-vs-Grade 2 |
6.200400E-01 |
| Grade 1-vs-Grade 3 |
3.320200E-02 |
| Grade 1-vs-Grade 4 |
1.737950E-02 |
| Grade 2-vs-Grade 3 |
1.039610E-02 |
| Grade 2-vs-Grade 4 |
1.802220E-02 |
| Grade 3-vs-Grade 4 |
4.114600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.04090003283375E-09 |
| Normal-vs-ccB subtype |
1.801190E-03 |
| ccA subtype-vs-ccB subtype |
1.780420E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52411999999602E-05 |
| Normal-vs-N1 |
3.321800E-01 |
| N0-vs-N1 |
6.183800E-01 |
|
|
